Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients

NCT00558493 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bukwang Pharmaceutical